Article
Pan-cancer analysis of DNMT3A as a robust prognostic biomarker to predict the immunotherapy response
2023-07-31
Abstract excerpt
<h4>Background: </h4> DNA methyltransferase 3A (DNMT3A) is essential for de-novo methylation and cell development. Recent studies have shown that dysregulation of methylation regulated by DNMT3A is highly implicated in cancer progression. However, the regulatory roles of DNMT3A in various cancers are not completely clear and need further investigation. Methods The RNA-seq data in The Cancer Genome Atlas (TCGA) an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 587dc48c-fdad-5f0f-b774-63d078597b3e
- DOI
- 10.21203/rs.3.rs-3149495/v1
